MicroPort CardioFlow Medtech Corporation

SEHK:2160 Rapport sur les actions

Capitalisation boursière : HK$1.7b

MicroPort CardioFlow Medtech Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Jeffrey R Lindstrom

Directeur général

CN¥4.0m

Rémunération totale

Pourcentage du salaire du PDG59.8%
Durée du mandat du directeur général1.3yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction4.1yrs
Durée moyenne du mandat des membres du conseil d'administration3.8yrs

Mises à jour récentes de la gestion

Recent updates

MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable

Sep 27
MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable

After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar

Sep 27
After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar

Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?

Aug 07
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?

Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding

Jun 19
Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding

MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

May 29
MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

Apr 05
MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

Feb 23
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued

Jan 18
An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued

Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth

Oct 04
Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth

Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%

May 31
Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

May 23
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts

Apr 06
The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts

MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

Feb 08
MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

Oct 18
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate

Jun 30
We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate

Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts

Apr 04
Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts

MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Apr 03
MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued

Jan 21
An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued

Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?

Sep 05
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?

We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn

Jun 07
We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn

Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)

May 03
Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)

Analyse de la rémunération des PDG

Comment la rémunération de Jeffrey R Lindstrom a-t-elle évolué par rapport aux bénéfices de MicroPort CardioFlow Medtech?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-CN¥349m

Mar 31 2024n/an/a

-CN¥410m

Dec 31 2023CN¥4mCN¥2m

-CN¥472m

Rémunération vs marché: La rémunération totale de Jeffrey R ($USD 564.57K ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 359.95K ).

Rémunération et revenus: Données insuffisantes pour comparer la rémunération de Jeffrey R avec les performances de l'entreprise.


PDG

Jeffrey R Lindstrom (57 yo)

1.3yrs

Titularisation

CN¥4,004,000

Compensation

Mr. Jeffrey R Lindstrom is President, Executive Director & General Manager of MicroPort CardioFlow Medtech Corporation from August 29, 2023. He served as senior director of engineering in Edwards Lifescien...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Jeffrey R Lindstrom
President1.3yrsCN¥4.00mpas de données
Liang Zhao
Executive Director & First VP of Total Solutions2.5yrsCN¥3.91m0.058%
HK$ 1.0m
Luying Yan
VP & Executive Director4.2yrsCN¥2.70m0.042%
HK$ 718.8k
Xiangmei Li
Joint Company Secretary4.1yrspas de donnéespas de données
Lok Yee Chan
Joint Company Secretary4.1yrspas de donnéespas de données

4.1yrs

Durée moyenne de l'emploi

43yo

Âge moyen

Gestion expérimentée: L'équipe de direction de 2160 est considérée comme expérimentée (ancienneté moyenne 4.1 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Jeffrey R Lindstrom
President1.3yrsCN¥4.00mpas de données
Liang Zhao
Executive Director & First VP of Total Solutions2.5yrsCN¥3.91m0.058%
HK$ 1.0m
Luying Yan
VP & Executive Director4.2yrsCN¥2.70m0.042%
HK$ 718.8k
Jonathan H. Chou
Independent Non-Executive Director3.8yrsCN¥254.00kpas de données
Xia Wu
Non-Executive Director5.3yrspas de donnéespas de données
Guoming Chen
Non-Executive Chairman of the Board4.2yrsCN¥3.16m0.031%
HK$ 527.4k
Junjie Zhang
Non-Executive Director5.3yrspas de donnéespas de données
Zhixiang Sun
Independent Non-Executive Director3.8yrsCN¥254.00kpas de données
Jiandong Ding
Independent Non-Executive Director3.3yrsCN¥254.00k0.0012%
HK$ 21.2k

3.8yrs

Durée moyenne de l'emploi

47yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 2160 sont considérés comme expérimentés (ancienneté moyenne 3.8 ans).